The PERT Consortium® kindly invites you to the webinar Keeping up with Change: The Delta Variant and PE/DVT. COVID-19 has a complex association with VTE, with data series suggesting higher levels of both pulmonary embolism and in situ pulmonary vascular thrombosis. What is the impact of this on your patient and what does the increased transmissibility of the Delta variant mean we should expect from VTE presentations this winter?View
We are pleased to share with our friends and colleagues across the globe that: THE NATIONAL PERT CONSORTIUM HAS SUCCESSFULLY ENTERED 4000 UNIQUE PATIENTS INTO THE PERT CONSORTIUM QUALITY DATABASE. This is an incredible milestone and demonstrates a clear commitment from our members to advance the care of patients with Pulmonary Embolism.View
The PERT Consortium invites you to listen to a series of podcasts moderated by past immediate president of PERT Consortium Victor Tapson, MD, and joined by Alex Spyropoulos, MD, as they discuss dedicated DOAC trials that evaluated the treatment of pulmonary embolism including initial treatment, early discharge of low risk PE patients, and extension of treatment to reduce the risk of recurrence.View
Patients: Get the facts about pulmonary embolism, its causes, symptoms, and treatments.
Clinicians: Get the latest updates on pulmonary embolism care and treatment.